InvestorsHub Logo
Followers 132
Posts 14996
Boards Moderated 0
Alias Born 06/04/2018

Re: None

Thursday, 10/03/2019 2:20:28 PM

Thursday, October 03, 2019 2:20:28 PM

Post# of 73
News: $AXDX Studies Confirm Rapid Phenotypic Susceptibility Results Enable Earlier Antimicrobial Intervention and Better Patient Outcomes

TUCSON, Ariz. , Oct. 3, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. today announced presentation of full data from three outcome studies at IDWeek™ 2019. The full data being presented build upon the high-level findings that were first reported in the Company's September 18, ...

Find out more AXDX - Studies Confirm Rapid Phenotypic Susceptibility Results Enable Earlier Antimicrobial Intervention and Better Patient Outcomes
0.6939
-0.0061 (-0.87%)
Volume: 43,092
Day Range: 0.6913 - 0.769
Bid: 0.692
Ask: 0.6959
Last Trade Time: 12:50:22 PM EDT
Total Trades: 112
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXDX News